Cetuximab for the first-line treatment of metastatic colorectal cancer

Bibliographic Details
Main Authors: C Meads, J Round, S Tubeuf, D Moore, M Pennant, S Bayliss
Format: Article
Language:English
Published: NIHR Journals Library 2010-05-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta14Suppl1/01
_version_ 1828387856793468928
author C Meads
J Round
S Tubeuf
D Moore
M Pennant
S Bayliss
author_facet C Meads
J Round
S Tubeuf
D Moore
M Pennant
S Bayliss
author_sort C Meads
collection DOAJ
first_indexed 2024-12-10T06:01:15Z
format Article
id doaj.art-ff5e6337ad0c40b7baf959668e7de7fe
institution Directory Open Access Journal
issn 1366-5278
language English
last_indexed 2024-12-10T06:01:15Z
publishDate 2010-05-01
publisher NIHR Journals Library
record_format Article
series Health Technology Assessment
spelling doaj.art-ff5e6337ad0c40b7baf959668e7de7fe2022-12-22T01:59:48ZengNIHR Journals LibraryHealth Technology Assessment1366-52782010-05-0114 Suppl 110.3310/hta14Suppl1/01Cetuximab for the first-line treatment of metastatic colorectal cancerC Meads0J RoundS TubeufD MooreM PennantS BaylissDepartment of Public Health, University of Birmingham, Birmingham, UKhttps://doi.org/10.3310/hta14Suppl1/01
spellingShingle C Meads
J Round
S Tubeuf
D Moore
M Pennant
S Bayliss
Cetuximab for the first-line treatment of metastatic colorectal cancer
Health Technology Assessment
title Cetuximab for the first-line treatment of metastatic colorectal cancer
title_full Cetuximab for the first-line treatment of metastatic colorectal cancer
title_fullStr Cetuximab for the first-line treatment of metastatic colorectal cancer
title_full_unstemmed Cetuximab for the first-line treatment of metastatic colorectal cancer
title_short Cetuximab for the first-line treatment of metastatic colorectal cancer
title_sort cetuximab for the first line treatment of metastatic colorectal cancer
url https://doi.org/10.3310/hta14Suppl1/01
work_keys_str_mv AT cmeads cetuximabforthefirstlinetreatmentofmetastaticcolorectalcancer
AT jround cetuximabforthefirstlinetreatmentofmetastaticcolorectalcancer
AT stubeuf cetuximabforthefirstlinetreatmentofmetastaticcolorectalcancer
AT dmoore cetuximabforthefirstlinetreatmentofmetastaticcolorectalcancer
AT mpennant cetuximabforthefirstlinetreatmentofmetastaticcolorectalcancer
AT sbayliss cetuximabforthefirstlinetreatmentofmetastaticcolorectalcancer